31st Annual Luau and Legends of Surfing Invitational
|
The Moores Luau and Legends Invitational this past weekend was a huge success. Moores Director Diane Simeone, MD explained to the San Diego Union Tribune how this special surf competition stands out from all the others: it unites the community with the shared objective of combating cancer. Many thanks to all the volunteers who made this year’s event possible.
|
Annual Advances in Breast Cancer: Updates from International Medical Meetings
|
Featuring Moores Members who are experts in breast oncology, this educational opportunity provided by the UC San Diego, School of Medicine will emphasize clinical advances in breast oncology that have emerged from presentations at recent international meetings (e.g., ASCO, ESMO, and SABC).
|
|
|
Moores Member Awarded Grant from International Space Station National Laboratory and NASA Biological and Physical Sciences Division
|
Moores Member Catriona Jamieson, PhD has been awarded $2 million to advance pioneering work on a cancer kill switch, which will harness space science innovations to develop new cancer therapies.
|
This Friday, September 6, 2024, Ahmed O. Kaseb, MD, Professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, wll present “How to Empower Your Team to Conquer Cancer: Lessons Learned from MD Anderson Liver Cancer Program."
|
|
|
Department of Surgery Research Resident Boot Camp (RRBC)
|
The annual UC San Diego, School of Medicine, Department of Surgery Research Resident Boot Camp all-day symposium not only introduced the latest crop of residents to the realities of academic research, but also improved the research skills of residents who previously have attended the RRBC. This year’s RRBC featured (1) short talks on clinical research, study design, data analysis, and manuscript and abstract preparation and (2) opportunities to network with peers and receive feedback on ideas for research projects.
|
Moores Data Manager Awarded Lean Sigma Six (LSS) Green Belt Scholarship Award
|
Joseph Steidl has been awarded an LSS Green Belt Scholarship Award to streamline the grant data collection process that occurs quarterly at Moores. This data is used for metrics and reporting for the Moores NCI P30 Cancer Center Support Grant and the External Advisory Board. Currently, this process of (1) gathering grant data from UCSD, SDSU, and LJI for approximately 300 Moores Members, (2) cleaning the data, (3) ensuring the quality of the data, and (4) uploading the data to the Moores database takes 4 to 6 weeks. Through the LSS Award, Joseph will create and implement processes to cut this process time in half, which will allow Moores administration to provide more timely updates and high quality information to Moores leadership.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
|
This award is for clinician scientists who perform NCI-funded clinical trials research. It provides stable research career opportunities for clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in (1) developing national clinical trials, (2) implementing NCI clinical trials in their institutions, and, (3) providing national service to the NCI clinical trials networks through serving on scientific review committees, monitoring committees, and other activities—not serving as principal investigators of research projects. This award provides salary support and sufficient autonomy so that clinician scientists are not dependent solely on NCI grants held by others or other sources of support, to ensure career continuity.
|
|
|
| Robust genome and cell engineering via in vitro and in situ circularized RNAs
|
Nature Biomedical Engineering
|
Prashant Mali, PhD (Cancer Biology and Signaling)
|
|
|
| Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2
|
Proceedings of the National Academy of Sciences of the United States of America
|
Tatiana Kisseleva, MD, PhD (Cancer Biology and Signaling), Rohit Loomba, MD (Cancer Control Program), Christopher K. Glass, MD, PhD (Cancer Biology and Signaling)
|
| |
|
Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation, and extracellular matrix reorganization in the tumor microenvironment
|
Journal for ImmunoTherapy of Cancer
|
Judith A. Varner, PhD (Solid Tumor Therapeutics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
OP-1250-301: A Phase III Randomized, Open-label Study of OP1250 Monotherapy vs Standard of Care for the Treatment of ER, HER2 Advanced, or Metastatic Breast Cancer Following Endocrine and CDK 4/6 Inhibitor Therapy (OPERA01)
|
PI: Angelique Richardson, MD, PhD
NCT: NCT06016738
|
EDGE-Lung: A Phase II, Open-label, Platform Study to Evaluate Immunotherapy-based Combinations in Participants with Advanced Non-Small Cell Lung Cancer
|
PI: Sandip Patel, MD
NCT: NCT05676931
|
|
|
COMMUNITY OUTREACH & ENGAGEMENT (COE) |
Kick the Flu +2 Summit with San Diego Protecting Against HPV (SD PATH)
|
COE attended the 20th Annual Kick the Flu +2 Summit on behalf of SD PATH on August 29, 2024 and provided cancer prevention education and HPV and vaccine resources. COE looks forward to continuing this collaboration to promote HPV vaccination and community awareness.
|
|
|
Click here to share your recent publications, awards, honors, or grants. We want to know about the accomplishments of our members.
|
|
|
|
